UPDATE 1-Kite Pharma's cancer drug clears main goal in study

Feb 28 (Reuters) - Kite Pharma Inc said on Tuesday

its experimental CAR T-cell therapy, which helps the immune

system fight cancer, was highly effective in treating aggressive

non-Hodgkin lymphoma, meeting the main goal of a key study.

Read more